Literature DB >> 1709666

The use of adenovirus-infected HeLa cells for the detection of low titer autoantibodies.

R Slobbe1, B Van Esch, T Kveder, W J Van Venrooij.   

Abstract

Following infection of HeLa cells with adenovirus type 5 the cellular La protein becomes predominantly associated with the virally encoded RNA polymerase III products VAI, and VAII, while most of the host RNA polymerase II (e.g. U1, U2, U4, U5 and mRNA) and RNA polymerase III transcription (e.g. U6 and pre-tRNAs) ceases. Other RNA polymerase III products such as the cellular Ro RNAs continue to be transcribed and assembled into ribonucleoprotein complexes containing the Ro (SS-A) antigens. Using a 32P-pulse chase-labeled, adenovirus-infected HeLa cellular extract as a source of antigen, anti-La (SS-B) and anti-Ro (SS-A) antibodies can be detected simultaneously using an immunoprecipitation assay. In the present study this method was found to be more sensitive in detecting anti-La antibodies then counter immunoelectrophoresis and immunoblotting. In studies of sera from patients suffering from rheumatic diseases the percentage positive for anti-La antibody was significantly elevated using this method, especially in patients with systemic lupus erythematosus.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1709666     DOI: 10.1016/0022-1759(91)90172-c

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  7 in total

1.  Refined definition of the 56K and other autoantigens in the 50-60 kDa region.

Authors:  G J Pruijn; B Bozic; F Schoute; L A Rokeach; W J van Venrooij
Journal:  Mol Biol Rep       Date:  1992-09       Impact factor: 2.316

2.  Analysis of parotid glands of primary Sjögren's syndrome patients using proteomic technology reveals altered autoantigen composition and novel antigenic targets.

Authors:  E A Stea; J G Routsias; M Samiotaki; G Panayotou; E Papalambros; H M Moutsopoulos; A G Tzioufas
Journal:  Clin Exp Immunol       Date:  2007-01       Impact factor: 4.330

3.  Preferential recognition of the phosphorylated major linear B-cell epitope of La/SSB 349-368 aa by anti-La/SSB autoantibodies from patients with systemic autoimmune diseases.

Authors:  A G Terzoglou; J G Routsias; S Avrameas; H M Moutsopoulos; A G Tzioufas
Journal:  Clin Exp Immunol       Date:  2006-06       Impact factor: 4.330

Review 4.  Anti-Ro(SSA) and anti-La(SSB) antibodies in autoimmune rheumatic diseases.

Authors:  P Youinou; Y Adler; S Muller; A Lamour; D Baron; R L Humbel
Journal:  Clin Rev Allergy       Date:  1994

5.  Purification and characterization of human autoantibodies directed to specific regions on U1RNA; recognition of native U1RNP complexes.

Authors:  R M Hoet; B Kastner; R Lührmann; W J van Venrooij
Journal:  Nucleic Acids Res       Date:  1993-11-11       Impact factor: 16.971

6.  Detection and occurrence of the 60- and 52-kD Ro (SS-A) antigens and of autoantibodies against these proteins.

Authors:  R L Slobbe; G J Pruijn; W G Damen; J W van der Kemp; W J van Venrooij
Journal:  Clin Exp Immunol       Date:  1991-10       Impact factor: 4.330

Review 7.  Ro/SS-A and La/SS-B: autoantigens in Sjögren's syndrome?

Authors:  R J Smeenk
Journal:  Clin Rheumatol       Date:  1995-07       Impact factor: 2.980

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.